Market cap
$408.2B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-19
Alerts
8
Price$166.15 +20.01% 3M daily closessample
167.63135.19
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 27INS
- Oct 22INS
- Oct 19SEC
- Oct 13INS
- Oct 07INS
- Sep 29INS
- Sep 18SEC
- Sep 09INS
Company facts
SEC EDGAR registration- Name
- CG Oncology, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- -24sample, -100 to +100
- Reporting currency
- USD
Who is positioning in CGON
sample- Insiders
- 34 insider transactions over 90 days, net selling, $530.0M
- Congress
- No member trades over 90 days
- Institutions · 13F
- 25 funds hold $3.4B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$22.5B +16.8% y/y
Q4 2024Q3 2026
Inventory$13.2B +11.9% y/y
Q4 2024Q3 2026
Accounts receivable$10.4B +18.4% y/y
Q4 2024Q3 2026
Total debt$26.4B +12.0% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $81.2B -0.8% 3M
- Sample peer B
- $266.4B +3.2% 3M
- Sample peer C
- $321.9B +0.2% 3M
- Sample peer D
- $383.8B -9.8% 3M
- Sample peer E
- $82.8B +1.5% 3M